36
Views
108
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Serum Response Factor Is Required for Immediate-Early Gene Activation yet Is Dispensable for Proliferation of Embryonic Stem Cells

, , , , , , , & show all
Pages 2933-2943 | Received 20 Nov 2000, Accepted 26 Jan 2001, Published online: 28 Mar 2023
 

Abstract

Addition of serum to mitogen-starved cells activates the cellular immediate-early gene (IEG) response. Serum response factor (SRF) contributes to such mitogen-stimulated transcriptional induction of many IEGs during the G0-G1 cell cycle transition. SRF is also believed to be essential for cell cycle progression, as impairment of SRF activity by specific antisera or antisense RNA has previously been shown to block mammalian cell proliferation. In contrast, Srf−/− mouse embryos grow and develop up to E6.0. Using the embryonic stem (ES) cell system, we demonstrate here that wild-type ES cells do not undergo complete cell cycle arrest upon serum withdrawal but that they can mount an efficient IEG response. This IEG response, however, is severely impaired in Srf−/− ES cells, providing the first genetic proof that IEG activation is dependent upon SRF. Also, Srf−/− ES cells display altered cellular morphology, reduced cortical actin expression, and an impaired plating efficiency on gelatin. Yet, despite these defects, the proliferation rates of Srf−/− ES cells are not substantially altered, demonstrating that SRF function is not required for ES cell cycle progression.

ACKNOWLEDGMENTS

G. Schratt and B. Weinhold contributed equally to this work.

We thank Marianne Petry for expert technical assistance. We acknowledge the gift of anti-E-cadherin antiserum from H. Beug (IMP, Vienna, Austria). We appreciate the comments on this manuscript by O. Heidenreich.

This work was supported through grants of the VolkswagenStiftung (I/74039 to U.R. and I/74043 to A.N.) and the DFG (NO 120/10-1 and NO 120/7-4 to A.N.). A.S.L. and R.A.W. acknowledge financial support through NIH grant R35CA39826.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.